The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

Dr. Marty Makary, FDA Commissioner, discusses the reforms the FDA is making towards reducing the price of IVF medications. He ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...

The Pakistan People's Party (PPP) has given the government one month to fulfill its promises.

U.S. federal agencies have begun scrutinizing lenders for potential misconduct when distributing $525 billion in pandemic aid to struggling small businesses, according to half a dozen people with ...

JPMorgan Chase & Co is investigating employees who may have been involved in the misuse of federal funds meant to help small businesses and other customers hurt by COVID-19 shutdowns, according to an ...

Iowa Republican U.S. Rep. Ashley Hinson on Friday criticized the White House for a thread on Twitter that’s gone viral highlighting Republican lawmakers for criticizing student loan forgiveness after ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.

Shares of Revolution Medicines gained after the Food and Drug Administration granted a priority voucher to speed up the development and review of the company's cancer treatment. The stock rose 8.9% to ...

FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned ...